T266M (p.Thr266Met) variant of ETFA (P13804)
T266M (p.Thr266Met) in ETFA (P13804) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of ETFA-related disorders; Glutaric acidemia type 2A; Inborn genetic diseases. The available variant effect predictions contribute to a CATVariant prioritization score of 0.91 / 1. The record also includes population frequency data, published literature, and structural context.
T266M (p.Thr266Met) variant details
- p.Thr266Met
- rs119458970
- ClinGen CA115638
- ClinVar RCV000002712
- ClinVar RCV000185868
- Pathogenic
- ETFA-related disorders; Glutaric acidemia type 2A; Inborn genetic diseases
- Missense
- Variant Prioritization Score for Impact Estimate 0.913
- REVEL 0.94
- ESM-1b 1.00
- AlphaMissense 0.99
- CADD 32.00
- PolyPhen-2 1.00
- SIFT 0.00
- ClinVar: Pathogenic (ETFA-related disorders; Glutaric acidemia type 2A; Inborn geneti)
- EBI: Pathogenic (in GA2A)
- UniProt: Pathogenic (in GA2A)
- Most common in the Ashkenazi Jewish population (allele frequency 0.00029)
- Structural context available
- Cited in: Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation… (PMID 12815589)
- Cited in: Glutaric acidemia type II. Heterogeneity in beta-oxidation flux, polypeptide synthesis, and complementary DNA mutations… (PMID 1430199)